| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA676676 | F | In vitro growth inhibition against Entamoeba histolytica | Entamoeba histolytica | 102 | organism-based format | Scientific Literature | ||
| 2. | ALA681824 | F | Inhibitory activity, for stimulation of TNF-alpha release in gamma-delta T cells, using a constrained maximum TNF-alpha release of 2700 pg/mL | Homo sapiens | 61 | cell-based format | Scientific Literature | ||
| 3. | ALA681825 | F | Inhibitory activity, for stimulation of TNF-alpha release in gamma-delta T cells, using individual observed maximum TNF-alpha release | Homo sapiens | 45 | cell-based format | Scientific Literature | ||
| 4. | ALA681826 | F | pIC50 value for stimulation of TNF-alpha release in gamma-delta T cells, using a constrained maximum TNF-alpha release of 2700 pg/mL | Homo sapiens | 61 | cell-based format | Scientific Literature | ||
| 5. | ALA681827 | F | pIC50 value for stimulation of TNF-alpha release in gamma-delta T cells, using individual observed maximum TNF-alpha release | Homo sapiens | 45 | cell-based format | Scientific Literature | ||
| 6. | ALA681890 | B | Inhibitory activity against farnesyl Pyrophosphate Synthase was determined | Leishmania major | 61 | single protein format | Scientific Literature | ||
| 7. | ALA681891 | B | Binding affinity towards farnesyl Pyrophosphate Synthase using [14C]- isopentenyl pyrophosphate as radioligand | Leishmania major | 62 | single protein format | Scientific Literature | ||
| 8. | ALA857167 | B | Inhibitory activity against farnesyl Pyrophosphate Synthase expressed as #NAME? (M) | Leishmania major | 61 | single protein format | Scientific Literature | ||
| 9. | ALA681671 | B | Inhibitory activity against the human recombinant geranylgeranyl diphosphate synthase (GGPPSase). | 29 | single protein format | Scientific Literature | |||
| 10. | ALA699877 | A | 50% lethal dose for inhibition of KB cells growth | Homo sapiens | 27 | cell-based format | Scientific Literature | ||
| 11. | ALA700364 | T | Toxicity evaluated against human nasopharyngeal carcinoma KB cell line | Homo sapiens | 102 | cell-based format | Scientific Literature | ||
| 12. | ALA769481 | F | In vitro growth inhibition against Plasmodium falciparum | Plasmodium falciparum | 102 | organism-based format | Scientific Literature | ||
| 13. | ALA786021 | F | Bone resorption activity in rats. | Rattus norvegicus | 35 | organism-based format | Scientific Literature | ||
| 14. | ALA817404 | F | In vitro growth inhibition of bloodstream-form Trypanosoma brucei rhodesiense Trypomastigotes | Trypanosoma brucei rhodesiense | 27 | organism-based format | Scientific Literature | ||
| 15. | ALA873468 | F | Predicted pIC50 against Trypomastigotes Brucei rhodesiense. | Trypanosoma brucei rhodesiense | 21 | organism-based format | Scientific Literature | ||
| 16. | ALA850290 | A | Therapeutic index measured as the ratio of LD50 (KB cells) to IC50 (T.b. rhodesiense) | Trypanosoma brucei rhodesiense | 27 | cell-based format | Scientific Literature | ||
| 17. | ALA835402 | A | Therapeutic index (TI) value as ratio of lethal dose (LD50) to the inhibitory concentration (IC50) | 41 | cell-based format | Scientific Literature | |||
| 18. | ALA874944 | F | In vitro inhibitory concentration against the growth of Toxoplasma gondii in human foreskin fibroblast monolayer cells (HFF cells) | 60 | cell-based format | Scientific Literature | |||
| 19. | ALA836410 | F | Lethal dose required to inhibit the growth of human KB (nasopharyngeal carcinoma) cell line | Homo sapiens | 41 | cell-based format | Scientific Literature | ||
| 20. | ALA1217000 | F | Antimicrobial activity against Plasmodium falciparum | Plasmodium falciparum | 630 | organism-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!